Chitosan as a novel nasal delivery system for vaccines

Advanced Drug Delivery Reviews

Volumn 51, Issue 1-3, 2001, Pages 81-96

  Illum, L ^a   Jabbal Gill, I ^a   Hinchcliffe, M ^a   Fisher, A N ^a   Davis, S S ^a  

^a Drug Delivery and Clinical Research Centre Ltd   (United Kingdom)

Author keywords

Chitosan; Diphtheria; DNA delivery; Influenza; Nasal vaccines; Pertussis; Phase I clinical study

Indexed keywords

CELLS; NANOSTRUCTURED MATERIALS; POLYSACCHARIDES; PROTEINS;

PARENTERAL ADMINISTRATION;

VACCINES;

CHITOSAN; DIPHTHERIA VACCINE; DNA VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE;

CHEMICAL STRUCTURE; DIPHTHERIA; DRUG DELIVERY SYSTEM; HUMAN; INFLUENZA; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; REVIEW; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; CHITIN; CHITOSAN; DIPHTHERIA TOXOID; DRUG DELIVERY SYSTEMS; HUMANS; INFLUENZA VACCINES; PERTUSSIS VACCINE; VACCINES; VACCINES, DNA;

EID: 0035940314     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00171-5     Document Type: Review

References (29)

1. Intranasal immunization with influenza vaccine
2. Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
3. The efficacy of live attenuated, cold adapted, trivalent, intranasal influenza virus vaccine in children
4. New approaches to antigen delivery
5. Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunisation using live staphylococci with surface-displayed RSV-peptides
6. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)
7. Immunology of the tonsils
8. The role of nasopharyngeal lymphoid tissue
9. Nasal-associated lymphoid tissue
10. Mucosally delivered vaccine against diphtheria; formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
11. Evaluation of the clearance characteristics of bioadhesive systems in humans
12. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens
13. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
14. Crystallized dextran nanospheres with entrapped antigen and their use as adjuvants
15. Polymer-grafted starch microparticles for oral and nasal immunization
16. Bioadhesive microspheres as a potential nasal drug delivery system
17. Hyaluronic acid ester microspheres as a nasal delivery system for insulin
18. Chitosan and its use as a pharmaceutical excipient
19. Chitosan as a novel nasal delivery system for peptide drugs
20. Bioadhesive formulations for nasal peptide delivery
21. Novel chitosan based delivery systems for nasal administration of a LHRH-analogue
22. Effect of chitosan on epithelial permeability and structure
23. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice
24. Prevention and control of influenza: Part 1, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (AGIP)
25. Note for guidance on hormonisation of requirements for influenza vaccines
26. Clearance characteristics of chitosan based formulations in the sheep nasal cavity
27. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery
28. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine peanut allergy model
29. Chitosan and depolymerised chitosan oligomers as condensing carriers for in vivo plasmid delivery